Electromed (ELMD) Net Equity Issued and Repurchased (2010 - 2019)

Electromed's (ELMD) quarterly Net Equity Issued and Repurchased came in at $13040.0 in Q3 2019, down 61.15% year-on-year from $33568.0 in Q3 2018, and down 61.15% on a QoQ basis from $33568.0 in Q3 2018.

Electromed (ELMD) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends

Electromed (ELMD) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $13040.0 in Q3 2019.

  • On a quarterly basis, Net Equity Issued and Repurchased fell 61.15% year-over-year to $13040.0 in Q3 2019; TTM through Sep 2019 was $46608.0, a 71.59% increase from a year earlier, with the FY2012 full-year figure at $5.9 million, down 6.56% from the prior year.
  • Net Equity Issued and Repurchased for Q3 2019 stood at $13040.0, down from $33568.0 in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for ELMD reached as high as $33568.0 in Q3 2018 and fell as low as $13040.0 in Q3 2019.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Electromed 313.26 Mn 296.27 Mn 14.64 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 13,040.00
Sep 30, 2019 13,040.00
Sep 30, 2018 33,568.00
Sep 30, 2018 33,568.00
Dec 31, 2010 -6,405.00
Dec 31, 2010 -6,405.00
Sep 30, 2010 6.37 Mn
Sep 30, 2010 6.37 Mn